Dibenzocyclooctadiene lignans, gomisins J and N inhibit the Wnt/β-catenin signaling pathway in HCT116 cells

Biochemical and Biophysical Research Communications

Volumn 428, Issue 2, 2012, Pages 285-291

  Kang, Kyungsu ^a   Lee, Kyung Mi ^a   Yoo, Ji Hye ^a   Lee, Hee Ju ^a   Kim, Chul Young ^a,b   Nho, Chu Won ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

Cancer chemoprevention; Cyclin D1; Dibenzocyclooctadiene lignan; Gomisin; Schisandra chinensis; Wnt catenin

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CATENIN; CASPASE 3; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; GOMISIN; TRANSCRIPTION FACTOR E2F1; WNT PROTEIN;

APOPTOSIS; ARTICLE; CELL POPULATION; CELL PROLIFERATION; CELL STRAIN HCT116; CELL SURVIVAL; CELL VIABILITY; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DNA SEQUENCE; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; WNT SIGNALING PATHWAY;

APOPTOSIS; BETA CATENIN; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; CYCLIN D1; CYCLOOCTANES; G0 PHASE; G1 PHASE; HCT116 CELLS; HUMANS; LIGNANS; POLYCYCLIC COMPOUNDS; REGULATORY SEQUENCES, NUCLEIC ACID; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; WNT PROTEINS;

SCHISANDRA CHINENSIS;

EID: 84869204968     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.10.046     Document Type: Article

References (26)

1. Tarapore R.S., Siddiqui I.A., Mukhtar H. Modulation of Wnt/β-catenin signaling pathway by bioactive food components. Carcinogenesis 2012, 33:483-491.
2. Teiten M.H., Gaascht F., Dicato M., et al. Targeting the wingless signaling pathway with natural compounds as chemopreventive or chemotherapeutic agents. Curr. Pharm. Biotechnol. 2012, 13:245-254.
3. Park C.H., Chang J.Y., Hahm E.R., et al. Quercetin, a potent inhibitor against β-catenin/Tcf signaling in SW480 colon cancer cells. Biochem. Biophys. Res. Commun. 2005, 328:227-234.
4. Kang K., Oh S.H., Yun J.H., et al. A novel topoisomerase inhibitor, daurinol, suppresses growth of HCT116 cells with low hematological toxicity compared to etoposide. Neoplasia 2011, 13:1043-1057.
5. Saleem M., Kim H.J., Ali M.S., et al. An update on bioactive plant lignans. Nat. Prod. Rep. 2005, 22:696-716.
6. Yoo J.H., Lee H.J., Kang K., et al. Lignans inhibit cell growth via regulation of Wnt/β-catenin signaling. Food Chem. Toxicol. 2010, 48:2247-2252.
7. Shen W., Zou X., Chen M., et al. Effects of diphyllin as a novel V-ATPase inhibitor on gastric adenocarcinoma. Eur. J. Pharmacol. 2011, 667:330-338.
8. Panossian A., Wikman G. Pharmacology of Schisandra chinensis Bail.: an overview of Russian research and uses in medicine. J. Ethnopharmacol. 2008, 118:183-212.
9. Choi Y.W., Takamatsu S., Khan S.I., et al. Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans. J. Nat. Prod. 2006, 69:356-359.
10. Kim J.H., Choi Y.W., Park C., et al. Apoptosis induction of human leukemia U937 cells by gomisin N, a dibenzocyclooctadiene lignan, isolated from Schizandra chinensis Baill. Food Chem. Toxicol. 2010, 48:807-813.
11. Lin S., Fujii M., Hou D.X. Molecular mechanism of apoptosis induced by schizandrae-derived lignans in human leukemia HL-60 cells. Food Chem. Toxicol. 2008, 46:590-597.
12. Oh S.Y., Kim Y.H., Bae D.S., et al. Anti-inflammatory effects of gomisin N, gomisin J, and schisandrin C isolated from the fruit of Schisandra chinensis. Biosci. Biotechnol. Biochem. 2010, 74:285-291.
13. Lee S.B., Kim C.Y., Lee H.J., et al. Induction of the phase II detoxification enzyme NQO1 in hepatocarcinoma cells by lignans from the fruit of Schisandra chinensis through nuclear accumulation of Nrf2. Planta Med. 2009, 75:1314-1318.
14. Kang K., Lee H.J., Kim C.Y., et al. The chemopreventive effects of Saussurea salicifolia through induction of apoptosis and phase II detoxification enzyme. Biol. Pharm. Bull. 2007, 30:2352-2359.
15. Kang K., Lee S.B., Jung S.H., et al. Tectoridin, a poor ligand of estrogen receptor α, exerts its estrogenic effects via an ERK-dependent pathway. Mol. Cells 2009, 27:351-357.
16. Morin P.J., Sparks A.B., Korinek V., et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997, 275:1787-1790.
17. Diehl J.A. Cycling to cancer with cyclin D1. Cancer Biol. Ther. 2002, 1:226-231.
18. Eastman A. Cell cycle checkpoints and their impact on anticancer therapeutic strategies. J. Cell. Biochem. 2004, 91:223-231.
19. DeGregori J., Kowalik T., Nevins J.R. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol. Cell. Biol. 1995, 15:4215-4224.
20. Choi H., Gwak J., Cho M., et al. Murrayafoline A attenuates the Wnt/β-catenin pathway by promoting the degradation of intracellular β-catenin proteins. Biochem. Biophys. Res. Commun. 2010, 391:915-920.
21. Gwak J., Song T., Song J.Y., et al. Isoreserpine promotes β-catenin degradation via Siah-1 up-regulation in HCT116 colon cancer cells. Biochem. Biophys. Res. Commun. 2009, 387:444-449.
22. Jedinak A., Thyagarajan-Sahu A., Jiang J., et al. Ganodermanontriol, a lanostanoid triterpene from Ganoderma lucidum, suppresses growth of colon cancer cells through β-catenin signaling. Int. J. Oncol. 2011, 38:761-767.
23. Min H.Y., Chung H.J., Kim E.H., et al. Inhibition of cell growth and potentiation of tumor necrosis factor-α (TNF-α)-induced apoptosis by a phenanthroindolizidine alkaloid antofine in human colon cancer cells. Biochem. Pharmacol. 2010, 80:1356-1364.
24. Park C.H., Hahm E.R., Lee J.H., et al. Ionomycin downregulates β-catenin/Tcf signaling in colon cancer cell line. Carcinogenesis 2005, 26:1929-1933.
25. MacDonald B.T., Tamai K., He X. Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev. Cell 2009, 17:9-26.
26. Yim S.Y., Lee Y.J., Lee Y.K., et al. Gomisin N isolated from Schisandra chinensis significantly induces anti-proliferative and pro-apoptotic effects in hepatic carcinoma. Mol. Med. Report. 2009, 2:725-732.